logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
CRVS
Corvus Pharmaceuticals, Inc.
12.56
2 x 10.15
2 x 18.20
bid
ask
+
0.01
0.08%
2 @ 07:30 PM
12.38 -0.18 (1.43%)
Ytd63.12%
1y105.23%
12.26
day range
12.61
5.74
52 week range
26.95
Open12.53Prev Close12.55Low12.26High12.61Mkt Cap1.06B
Vol4.46MAvg Vol1.08MEPS-0.64P/EN/AForward P/E-11.77
Beta0.86Short Ratio25.31Inst. Own85.81%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0350-d Avg14.03200-d Avg13.991yr Est33.14

CRVS News

Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
globenewswire.com
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
globenewswire.com
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Ph

Data supports ongoing registration Phase 3 trial in r/r PTCL, Phase 2 trial in atopic dermatitis and

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript
seekingalpha.com
Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Corvus Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com
Corvus Pharmaceuticals Q2 Earnings Call Highlights

Corvus Pharmaceuticals NASDAQ: CRVS reported a wider second-quarter loss as it increased spending on
benzinga.com
Corvus Pharma Q2 EPS $(0.19) Misses $(0.17) Estimate

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.19) per share which missed the analyst

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results

Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PT

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on Augus

Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT Company to host conference ca

Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 5.1% – Should You Buy?
defenseworld.net
Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 5.1% – Should You Buy?

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS - Get Free Report) were up 5.1% during mid-day

10 Health Care Stocks With Whale Alerts In Today’s Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy?
fool.com
Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy?

David Scott Moore acquired 21,700 common shares for a transaction value of approximately $250,000 on
benzinga.com
Corvus Pharma Participates In New $13.5M Financing For Angel Pharmaceuticals

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announ

Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
globenewswire.com
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Devel

SOUTH SAN FRANCISCO, Calif. , June 09, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq

Corvus Pharmaceuticals, Inc. (CRVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com
Corvus Pharmaceuticals, Inc. (CRVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

Corvus Pharmaceuticals, Inc. (CRVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sac

SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:

Corvus Pharmaceuticals: The Market Is Pricing Atopic Dermatitis Success Too Early
seekingalpha.com
Corvus Pharmaceuticals: The Market Is Pricing Atopic Dermatitis Success Too Early

Corvus Pharmaceuticals, Inc. remains a Sell as its valuation has run ahead of fundamentals following

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
fool.com
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer

Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call Transcript
seekingalpha.com
Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call Transcript

Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call Transcript

Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
globenewswire.com
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Inves

New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to inc

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive dat

Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D.
globenewswire.com
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D.

SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
globenewswire.com
Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitini

Two oral presentations including late-breaker at SID  Data will cover Phase 1 clinical trial of soqu

Crude Oil Tumbles 12%; State Street Posts Upbeat Earnings
benzinga.com
Crude Oil Tumbles 12%; State Street Posts Upbeat Earnings

Stocks traded higher with Dow Jones up by 1,000 points. Consumer discretionary shares rose while ene

Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday
benzinga.com
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks

The Dow Jones index rose 700 points, Autoliv Inc (NYSE: ALV) reported strong results causing a jump

This Woodward Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
This Woodward Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Rating of “Moderate Buy” by Analysts
defenseworld.net
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Given Average Rating of “Moderate Buy” by Analysts

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS - Get Free Report) have been given a consensus

Earnings Scheduled For March 12, 2026
benzinga.com
Earnings Scheduled For March 12, 2026

Revolution Medicines, Erasca And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Revolution Medicines, Erasca And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Crude Oil Gains 2%; D.R. Horton Earnings Top Views
benzinga.com
Crude Oil Gains 2%; D.R. Horton Earnings Top Views

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Corvus Pharmaceuticals, Immunitybio, Acadia Healthcare And Other Big Stocks Moving Higher On Tuesday
benzinga.com
Corvus Pharmaceuticals, Immunitybio, Acadia Healthcare And Other Big Stocks Moving Higher On Tuesday

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For August 7, 2025
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
Earnings Scheduled For May 8, 2025
benzinga.com
Earnings Scheduled For March 25, 2025

This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga.com
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga.com
Dow Surges 150 Points, US Current Account Deficit Widens In Q3
benzinga.com
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premar
benzinga.com
Earnings Scheduled For November 12, 2024
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
Why Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
benzinga.com
Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a pro